ERK1/2 inhibitors (Celgene)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameERK1/2 inhibitors (Celgene)
Drug Alias Namecovalent ERK1/2 inhibitors (Celgene)extracellular signal related kinase 1/2 inhibitors (Celgene)CNX-5269
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionExtracellular-signal-regulated kinase 2 inhibitorsExtracellular-signal-regulated kinase1 inhibitors
TargetsExtracellular-signal-regulated kinase1Extracellular-signal-regulated kinase 2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCelgene Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCelgene Corp
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A